Flanders Vaccine is a strategy-driven non-profit organisation, supporting the development of immunotherapeutics and vaccines for both prophylactic and therapeutic targets in humans and animals by facilitating the exchange of know-how and complementary innovative technologies between academia and industry. The Flanders Vaccine platform can be seen as an integrated tool that gives rise to more and better partnerships; that prepares us better for future calls for funding; that enables us to network at inspiring meetings and conferences; that generates visibility and attracts significant attention from national and international experts, stakeholders and organisations.
Looking for a particular Flanders Vaccine employee's phone or email?
The Flanders Vaccine annual revenue was $4 million in 2026.
Flanders Vaccine is based in Diepenbeek, Flanders.
The NAICS codes for Flanders Vaccine are [325, 32541, 325414, 3254, 32].
The SIC codes for Flanders Vaccine are [28, 283].